Details for New Drug Application (NDA): 022408

✉ Email this page to a colleague

NDA 022408 describes NATROBA, which is a drug marketed by Cipher and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug. Additional details are available on the NATROBA profile page.

The generic ingredient in NATROBA is spinosad. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the spinosad profile page.

Summary for 022408

Tradename:	NATROBA
Applicant:	Cipher
Ingredient:	spinosad
Patents:	1

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for 022408

Generic Entry Date for 022408^: ⤷ Try for Free* Constraining patent/regulatory exclusivity: 9,895,388 Dosage: SUSPENSION;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for NDA: 022408

Suppliers and Packaging for NDA: 022408

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NATROBA	spinosad	SUSPENSION;TOPICAL	022408	NDA AUTHORIZED GENERIC	Allegis Pharmaceuticals, LLC	28595-570	28595-570-04	1 BOTTLE, PLASTIC in 1 CARTON (28595-570-04) / 120 mL in 1 BOTTLE, PLASTIC
NATROBA	spinosad	SUSPENSION;TOPICAL	022408	NDA AUTHORIZED GENERIC	ParaPRO LLC	52246-570	52246-570-04	1 BOTTLE, PLASTIC in 1 CARTON (52246-570-04) / 120 mL in 1 BOTTLE, PLASTIC

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SUSPENSION;TOPICAL			Strength	0.9%
Approval Date:	Jan 18, 2011	TE:		RLD:	Yes
Patent:	9,895,388	Patent Expiration:	Nov 25, 2033	Product Flag?		Substance Flag?		Delist Request?
Patented Use:	THE PRODUCT COMPOSITION (NATROBA) IS FOR THE TOPICAL TREATMENT OF HUMAN SCABIES MITE INFESTATIONS BY MELTING AND DELIVERING THE ACTIVE INGREDIENT, SPINOSAD, TO THE STRATUM CORNEUM WHERE SCABIES MITES LIVE AND BREED

Expired US Patents for NDA 022408

Show entries

Subscribe to access the full database, or Try for Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Cipher	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011	5,496,931	⤷ Try for Free
Cipher	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011	7,030,095	⤷ Try for Free
Cipher	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011	6,063,771	⤷ Try for Free
Cipher	NATROBA	spinosad	SUSPENSION;TOPICAL	022408-001	Jan 18, 2011	6,342,482	⤷ Try for Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Showing 1 to 4 of 4 entries

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.